Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Zeshen Wu"'
Autor:
Zeshen Wu, Yulu Peng, Longbin Xiong, Jun Wang, Zhen Li, Kang Ning, Minhua Deng, Ning Wang, Wensu Wei, Zhiyong Li, Pei Dong, Chunping Yu, Fangjian Zhou, Zhiling Zhang
Publikováno v:
Cancer Medicine, Vol 11, Iss 19, Pp 3674-3686 (2022)
Abstract Sunitinib is one of the first‐line targeted drugs for metastatic renal cell carcinoma (RCC) with dual effects of antiangiogensis and proapoptosis. Sam68 (Src‐associated in mitosis, 68 KDa), is found being involved in cell apoptosis. This
Externí odkaz:
https://doaj.org/article/c2a28f99e24840dca26deb11cf889c05
Autor:
Zhen Li, Yixin Huang, Diwei Zhao, Xin Luo, Zeshen Wu, Xinyi Zheng, Ye Xie, Yixuan Liu, Jianwei Wu, Yulu Peng, Yonghong Li, Fangjian Zhou
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundFew studies have focused on the performance of Briganti 2012, Briganti 2017 and MSKCC nomograms in the Chinese population in assessing the risk of lymph node invasion(LNI) in prostate cancer(PCa) patients and identifying patients suitable f
Externí odkaz:
https://doaj.org/article/48fc4667867e44b992a5d52e2d8b7de2
Autor:
Zhaohui Zhou, Longbin Xiong, Zeshen Wu, Lijuan Jiang, Yonghong Li, Zhiyong Li, Yulu Peng, Kang Ning, Xiangpeng Zou, Zefu Liu, Jun Wang, Zhen Li, Fangjian Zhou, Zhuowei Liu, Zhiling Zhang, Chunping Yu
Publikováno v:
Cell Death and Disease, Vol 13, Iss 5, Pp 1-11 (2022)
Abstract Multidrug resistance gene 1 (MDR1), a key factor contributing to drug insensitivity, has been associated with treatment failure and poor prognoses in various cancers, including bladder urothelial carcinoma (UC). Here we show that positive Nk
Externí odkaz:
https://doaj.org/article/92e494adb0064c2eb84c4c4ee5dd685b
Autor:
Minhua Deng, Ning Wang, Zhiyong Li, Rixin Chen, Jinling Duan, Yulu Peng, Zeshen Wu, Zhiling Zhang, Lijuan Jiang, Xianchong Zheng, Dan Xie, Wensu Wei, Zhuowei Liu, Fangjian Zhou
Publikováno v:
Cell Death and Disease, Vol 13, Iss 2, Pp 1-14 (2022)
Abstract RNA-binding proteins (RBPs) are key regulators of gene expression. RBP dysregulation is reported to play essential roles in tumorigenesis. However, the role of RBPs in urothelial carcinoma of the bladder (UCB) is only starting to be unveiled
Externí odkaz:
https://doaj.org/article/7d76cfc727534944ae40969c5000ecb9
Autor:
Kang, Ning, Zeshen, Wu, Xiangpeng, Zou, Huiming, Liu, Yi, Wu, Longbin, Xiong, Chunping, Yu, Shengjie, Guo, Hui, Han, Fangjian, Zhou, Pei, Dong, Zhiling, Zhang
Publikováno v:
Transl Androl Urol
BACKGROUND: Increasing number of patients with metastatic renal cell carcinoma (mRCC) are receiving subsequent programmed cell death protein-1 (PD-1) inhibitor combination therapy following tyrosine-kinase inhibitor (TKI) resistance. To explore wheth
Autor:
Zeshen Wu, Rixin Chen, Jin-Ling Duan, Wensu Wei, Minhua Deng, Yulu Peng, Zhiling Zhang, Fangjian Zhou, Jianye Liu, Zhiyong Li, Leye He, Dan Xie, Ning Wang, Lijuan Jiang, Xiao-Dan Ma
Publikováno v:
Cancer Science
Clinically, patients with urothelial carcinoma of the bladder (UCB) with tumor metastasis are incurable. To find new therapeutic strategies, the mechanisms underlying UCB invasion and metastasis should be further investigated. In this study, zinc fin
Autor:
Zhaohui Zhou, Longbin Xiong, Zeshen Wu, Lijuan Jiang, Yonghong Li, Zhiyong Li, Yulu Peng, Kang Ning, Xiangpeng Zou, Zefu Liu, Jun Wang, Zhen Li, Fangjian Zhou, Zhuowei Liu, Zhiling Zhang, Chunping Yu
Publikováno v:
Cell deathdisease. 13(5)
Multidrug resistance gene 1 (MDR1), a key factor contributing to drug insensitivity, has been associated with treatment failure and poor prognoses in various cancers, including bladder urothelial carcinoma (UC). Here we show that positive Nkx2.8 expr
Autor:
Pei Dong, Chunping Yu, Longbin Xiong, Ya Ding, Fangjian Zhou, Hui Han, Zeshen Wu, Shengjie Guo, Desheng Weng, Huiming Liu, Lijuan Jiang, Yulu Peng, Zhiling Zhang, Jianchuan Xia, Kang Ning
Publikováno v:
Journal of Urology. 206
Autor:
Zeshen Wu, De-Sheng Weng, Yulu Peng, Zhiling Zhang, Kang Ning, Lijuan Jiang, Chunping Yu, Shengjie Guo, Jian-Chuan Xia, Huiming Liu, Longbin Xiong, Pei Dong, Hui Han, Ya Ding, Fangjian Zhou
Publikováno v:
Transl Androl Urol
Background Radical/cytoreductive nephrectomy or nephron-sparing surgery may be thought to be not safe or unfeasible in some renal cell carcinoma (RCC) patients in which tumor is locally advanced or highly complicated. Neoadjuvant therapy may reduce t
Autor:
Longbin Xiong, Zeshen Wu, Fangjian Zhou, Zhiyong Li, Yulu Peng, Zhiling Zhang, Hui-Ming Lu, Min-Hua Deng, Kang Ning, Zhuowei Liu, Chunping Yu
Publikováno v:
International Journal of Surgery. 93:106058
Background The ileal conduit and ileal orthotopic neobladder were the most popular methods for urinary diversion following radical cystectomy. Stenting the anastomosis of ileo-ureter or ureter-neobladder was a common practice. However, it is still co